Sanofi Reaches Agreement With US Government To Lower Medicine Costs While Strengthening Innovation
I'm PortAI, I can summarize articles.
Sanofi has reached an agreement with the US government to lower medicine costs while investing $20 billion to upgrade US facilities. The agreement includes a three-year tariff-free period for imports and offers medicines at 70% savings through TrumpRx.gov. Sanofi will reduce prices by an average of 61% for certain medicines in the US, without impacting its growth strategy or financial outlook during the agreement period.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments